<p>Russian sovereign fund RDIF said on Friday it has achieved positive results from a small-scale study into the combined use of the AstraZeneca vaccine and the first component of the Sputnik V vaccine.</p>.<p><a href="https://www.deccanherald.com/tag/coronavirus" target="_blank"><strong>CORONAVIRUS SPECIAL COVERAGE ONLY ON DH</strong></a></p>.<p>"Preliminary data from the first 20 participants shows antibodies to the SARS-CoV-2 virus spike protein (S-protein) elicited in 100% of cases," RDIF said in a statement, citing a clinical trial carried out together with AstraZeneca in Azerbaijan. </p>
<p>Russian sovereign fund RDIF said on Friday it has achieved positive results from a small-scale study into the combined use of the AstraZeneca vaccine and the first component of the Sputnik V vaccine.</p>.<p><a href="https://www.deccanherald.com/tag/coronavirus" target="_blank"><strong>CORONAVIRUS SPECIAL COVERAGE ONLY ON DH</strong></a></p>.<p>"Preliminary data from the first 20 participants shows antibodies to the SARS-CoV-2 virus spike protein (S-protein) elicited in 100% of cases," RDIF said in a statement, citing a clinical trial carried out together with AstraZeneca in Azerbaijan. </p>